LFG
VIR icon

Larson Financial Group’s Vir Biotechnology VIR Stock Holding History

Larson Financial Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.28K Buy
420
+2
+0.5% +$19 ﹤0.01% 2842
2026
Q1 		$3.75K Sell
418
-1,000
-71% -$7.97K ﹤0.01% 2734
2025
Q4 		$8.55K Buy
1,418
+1,000
+239% +$5.95K ﹤0.01% 2205
2025
Q3 		$2.39K Buy
418
+407
+3,700% +$2.08K ﹤0.01% 2634
2025
Q2 		$55 Sell
11
-5
-31% -$27 ﹤0.01% 3224
2025
Q1 		$104 Hold
16
– – ﹤0.01% 2907
2024
Q4 		$117 Hold
16
– – ﹤0.01% 2570
2024
Q3 		$120 Hold
16
– – ﹤0.01% 2501
2024
Q2 		$142 Buy
+16
New +$153 ﹤0.01% 2173

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Larson Financial Group's VIR Position: Q2 2026 in Review

Larson Financial Group increased its Vir Biotechnology (VIR) stake by 0.48% in Q2 2026, buying an estimated $19 and bringing the position to 420 shares worth $4.28K. The position accounts for ﹤0.01% of the portfolio, ranked #2842.

Larson Financial Group first reported a position in VIR in Q2 2024 and has held it in 9 quarters since. The position peaked at $8.55K in Q4 2025. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Larson Financial Group held 420 shares of Vir Biotechnology worth $4.28K as of Q2 2026.
  • Larson Financial Group bought 2 Vir Biotechnology shares in Q2 2026, an estimated $19.
  • Vir Biotechnology made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2842 holding.
  • Larson Financial Group first reported a position in Vir Biotechnology in Q2 2024 and has held it in 9 quarters since.
  • Larson Financial Group's Vir Biotechnology position peaked at $8.55K in Q4 2025.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.